Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian Markets Pare Early Gains
Fri, 27 Mar 01:30 pm

Indian markets pared early gains as BSE-Sensex fell over 100 points and NSE-Nifty fell over 40 points in the mid-sessions. All the sectoral indices turned red apart from the IT sector which is trading with impressive gains of over 1%. FMCG, Healthcare and oil and gas have suffered the maximum losses. S&P BSE Midcap and S&P BSE Smallcap stocks have underperformed. While the midcap stocks fell over 1 %, smallcap stocks fell nearly 0.8% in today's session.

Commodities are trading with slight losses after posting robust gains owing to the war in Yemen. Gold prices, per 10 grams, fell nearly 0.3% or Rs 79 and are available at Rs 26,722 levels. Silver prices, per kilogram, fell 0.33% or Rs 126 and are available at Rs 38, 487 levels. Crude oil prices lost 2% after gaining by nearly 10% this week. Per barrel, crude oil prices fell Rs 65 and are available at Rs 3,188. The Indian rupee against the US Dollar declined about 0.14% or 0.09. Currently, the value of Indian Rupee against the U.S Dollar stands at Rs 62.58.

Capital goods are trading on sidelines between small losses and gains. Welspun Corp and L&T are, however, the top gainers in today's session. Shares of Larsen & Toubro gained over 1% after the company secured Rs 17.11 bn order across various segments. The company said that of the secured order Rs 8.8 bn is attributable towards building factory business while Rs 6.76 bn is attributable towards constructing power transmission and distribution businesses.

Healthcare companies have lost over 1.5% is today's trade. Leading pharma companies such Sun Pharma and Lupin have lost over 1% in the mid-session. Share prices of Cadila Healthcare are trading with slight losses of 0.3%. The company said that it acquired the remaining 50% stake in Zydus BSV, which is owned by Bharat Serums and Vaccines. Post this 50% stake acquisition, Zydus BSV has become a 100% subsidiary of Cadila Healthcare. Zydus BSV deals in manufacturing and selling approved anti-cancer agents on a global basis.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian Markets Pare Early Gains". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.